Home LiteratureArticle Details
PMID: 10051745 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway.

The European journal of neuroscience ·Vol. 11 ·No. 2 ·1999-02-00 ·Pages 441-8

Boutillier AL, Kienlen-Campard P, Loeffler JP

Abstract

Depolarization and subsequent calcium entry exert essential neuroprotective effects but the ultimate effector by which calcium blocks apoptosis is not known. Here we show that inhibition of calcium entry into cerebellar neurons by switching from high to low extracellular K+ concentrations (30-5 mM) induces apoptosis, that correlates with a rapid accumulation of cyclin D1 (CD1), an early marker of the G1/S transition of the cell cycle. These effects on apoptosis and cyclin D1 are mimicked either by blocking calcium entry into neurons (LaCl3, 100 microM or nifedipine, 10(-6) M) or by inhibiting the calcium/calmodulin pathway (calmidazolium, 10(-7) M). The increased CD1 protein levels do not result from a transcriptional upregulation of the CD1 gene by the Ca2+/calmodulin pathway but rather reflect an accumulation due to the lack of degradation by the proteasome-dependent pathway. Specific proteasome antagonists: carbobenzoxyl-leucinyl-leucinyl-norvalinal-H (MG-115), carbobenzoxyl-leucinyl-leucinyl-leucinal-H (MG-132) and clastolactacystin beta-lactone, induce neuronal apoptosis by themselves. Finally, this pathway is functional only at neuroprotective concentrations of K+ (30 mM), suggesting that calcium/CamK signalling pathway may regulate neuronal death by regulating the proteasome-mediated degradation activity of rapidly turning-over proteins (constitutively expressed genes or pre-existing pools of mRNA).

MeSH Terms
Animals Apoptosis/physiology Calcium/physiology Calmodulin/physiology Cerebellum/cytology Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors,metabolism Cyclin D1/genetics,metabolism Cysteine Endopeptidases/metabolism Cysteine Proteinase Inhibitors/pharmacology DNA Primers Enzyme Inhibitors/pharmacology Gene Expression/physiology Imidazoles/pharmacology In Situ Nick-End Labeling Isoquinolines/pharmacology Leupeptins/pharmacology Membrane Potentials/drug effects,physiology Mice Mice, Inbred Strains Multienzyme Complexes/metabolism Neurons/cytology,enzymology Potassium Chloride/pharmacology Protease Inhibitors/pharmacology Proteasome Endopeptidase Complex RNA, Messenger/analysis Signal Transduction/physiology Sulfonamides Ubiquitins/metabolism
Chemicals
Calmodulin Cysteine Proteinase Inhibitors DNA Primers Enzyme Inhibitors Imidazoles Isoquinolines Leupeptins Multienzyme Complexes Protease Inhibitors RNA, Messenger Sulfonamides Ubiquitins carbobenzoxy-leucyl-leucyl-norvalinal Cyclin D1 calmidazolium Potassium Chloride Cyclic AMP-Dependent Protein Kinases Cysteine Endopeptidases Proteasome Endopeptidase Complex N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide benzyloxycarbonylleucyl-leucyl-leucine aldehyde Calcium
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Boutillier A L
UMR 7519 CNRS, IPCB, Strasbourg, France.
Kienlen-Campard P
Loeffler J P
Article Info
Journal
The European journal of neuroscience
Abbr.
Eur J Neurosci
ISSN
0953-816X
Published
1999-02-00
Pages
441-8
Language
English
Region
France
NLM ID
8918110
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com